Phase II Study of Extensive Clinical Target Volumes in Postoperative Radiotherapy for Esophageal Squamous Cell Carcinoma; ODM derived from:


Versions (1) ▾
  1. 3/28/19
Copyright Holder:
Uploaded on:

March 28, 2019

No DOI assigned. To request one please log in.
Creative Commons BY 4.0
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Esophageal Squamous Cell Carcinoma NCT02384811

Eligibility Esophageal Squamous Cell Carcinoma NCT02384811

Inclusion Criteria
joined the study voluntarily and signed informed consent form;
age 18-75;ecog 0-2
esophageal squamous cell carcinoma , radical surgery ≤3 months,r0 resection. the operative incision healed well.
t3-4n0m0, t1-4n1-3m0 (according to ajcc2009)
no radiotherapy, chemotherapy or other treatments pre(post)surgery
ps ecog 0-2
life expectancy of more than 3 months
hemoglobin(hb)≥9 g/dl • wbc≥3x109/l, neutrophils (anc )≥1.5x109/l • platelet count (pt) ≥100x 109/l • hepatic function: alat and asat < 2.5 x uln, tbil<1.5 x uln •
renal function: creatinine < 1.5 x uln
no immuno-deficiency
use of an effective contraceptive for adults to prevent pregnancy.
Exclusion Criteria
complete esophageal obstruction after surgery, esophageal perforation, haematemesis
other malignant tumors, except for skin basal cell carcinoma, or cervical carcinoma in situ, who survived with no evidence disease for over 3 years
participation in other interventional clinical trials within 30 days
pregnant or breast-feeding women or people during the birth-period who refused to take contraceptives
drug addiction, alcoholism or aids
uncontrolled seizures or psychiatric diseases, loss of control over their own behavior
unsuitable to be enrolled in the trial in the opinion of the investigators